Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologists.
Furlan C, Arcangeli S, Avanzo M, Mirri MA, Munoz F, Giudici S, Perrone A, Amelio D, Tomio L, Draghini L, Deli AM, Pavanato G, Giuliano FM, Pontoriero A, Ciammella P, Navarria P, Iannalfi A, Buglione M, Guida C, Cammelli S, Iorio V, Cardinali M, Genovesi D, Barsacchi L, Balducci M, Bagnoli R, Berti F, Montesi G, Pasqualetti F, Bonome P, Santoni R, Doino D, Schirru P, Pinzi V, Borzillo V, Ferrarese F, Ferro M, Cicco L, Krengli M, Scoccianti S, Donato V. Furlan C, et al. Among authors: deli am. Tumori. 2018 Dec;104(6):466-470. doi: 10.5301/tj.5000615. Epub 2018 May 8. Tumori. 2018. PMID: 28315510
Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single-institute analysis of 742 patients.
Cozzarini C, Fiorino C, Da Pozzo LF, Alongi F, Berardi G, Bolognesi A, Briganti A, Broggi S, Deli A, Guazzoni G, Perna L, Pasetti M, Salvadori G, Montorsi F, Rigatti P, Di Muzio N. Cozzarini C, et al. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):191-9. doi: 10.1016/j.ijrobp.2010.09.027. Epub 2010 Nov 23. Int J Radiat Oncol Biol Phys. 2012. PMID: 21109361
Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?
Fodor A, Brombin C, Mangili P, Borroni F, Pasetti M, Tummineri R, Zerbetto F, Longobardi B, Perna L, Dell'Oca I, Deantoni CL, Deli AM, Chiara A, Broggi S, Castriconi R, Esposito PG, Slim N, Passoni P, Baroni S, Villa SL, Rancoita PMV, Fiorino C, Del Vecchio A, Bianchini G, Gentilini OD, Di Serio MS, Di Muzio NG. Fodor A, et al. Among authors: deli am. Breast. 2021 Feb;55:45-54. doi: 10.1016/j.breast.2020.12.004. Epub 2020 Dec 9. Breast. 2021. PMID: 33326894 Free PMC article.
Toxicity of Hypofractionated Whole Breast Radiotherapy Without Boost and Timescale of Late Skin Responses in a Large Cohort of Early-Stage Breast Cancer Patients.
Fodor A, Brombin C, Mangili P, Tummineri R, Pasetti M, Zerbetto F, Longobardi B, Galvan AS, Deantoni CL, Dell'Oca I, Castriconi R, Esposito PG, Deli AM, Rancoita PMV, Fiorino C, Vecchio AD, Di Serio MS, Di Muzio NG. Fodor A, et al. Among authors: deli am. Clin Breast Cancer. 2022 Jun;22(4):e480-e487. doi: 10.1016/j.clbc.2021.11.008. Epub 2021 Dec 1. Clin Breast Cancer. 2022. PMID: 34955430